← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× Synaptic Vesicle Cycle Hi
SNCA,MAPT,SNAP25,DNM1,VAMP2,CAV1 · neurodegeneration · comparative
Composite 0.760
Price $0.52
Evidence For 0
Evidence Against 0
Convergence hypothesis: Both α-synuclein (SNCA) in Parkinson's disease and tau (MAPT) in Alzheimer's disease exploit the same synaptic vesicle cycle machinery for trans-synaptic propagation, making the vesicle trafficking pathway a shared therapeutic target.
PD-specific mechanism: α-synuclein binds to synaptic vesicles (SYP, SV2A, SYNPR) at the presynaptic terminal, inducing conformational conversion of endogenous α-synuclein into β-sheet-rich oligomers. These oligomers traffic in both directio
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Synaptic Vesicle Cycle Hijacki Mechanistic 0.810 Evidence 0.700 Novelty 0.800 Feasibility 0.730 Impact 0.000 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence Synaptic Vesicle Cycle Hijacking: Shared Convergent Mechanis No evidence citations yet
Price History Overlay